Learn about the global injectable drug delivery devices market through The Business Research Company, which provides information on injectable drug delivery devices market size, injectable drug delivery devices market drivers and restraints, injectable drug delivery devices market players, the COVID-19 impact on the injectable drug delivery devices market, and more.

The injectable drug delivery devices market size is expected to grow from $36.51 billion in 2021 to $53.92 billion in 2026 at a rate of 8.1%. The injectable drug delivery devices market size is then expected to grow at a CAGR of 6.1% from 2026 and reach $72.57 billion in 2031.

A growing number of people with chronic conditions such as cancer, AIDS, diabetes, and thalassemia are projected to propel the demand for the injectable drug delivery devices market in the coming years.

Request A Sample For The Global Injectable Drug Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6382&type=smp

The injectable drug delivery devices market consists of sales of injectable drug delivery devices and related products such as conventional syringes, needle-free injectors, auto injectors and pen injectors by entities (organizations, sole traders, and partnerships). The market includes the sales of the injectable devices that have been extensively utilized for various routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and others to treat medical conditions ranging from cancer, diabetes to autoimmune disorders.

Global Injectable Drug Delivery Devices Market Segments Include:

By Type: Syringes, Injectors, Pumps

By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others

By End-User: Hospitals and Clinics, Home Healthcare Settings, Pharmaceutical and Biotechnological Companies, Research Laboratories, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the global injectable drug delivery devices market, accounting for 38.4% of the global market in 2021.

Microneedle-based injectable drug delivery systems are increasingly gaining traction because it is a highly efficient and versatile medical device technology, due to their distinguishing properties that include increase transdermal delivery, painless penetration, low cost, and relative safety. The microneedles are created using biodegradable polymers in which vaccines or drugs are encapsulated in the microneedles. The drug gets released once the microneedles dissolve in the skin. This delivery method helps a wider variety of molecules to pass the skin’s barrier, thus allowing the transdermal delivery to be applied to a large range of clinical applications including, severe osteoporosis, diabetes, and influenza vaccination. This is a smart approach and increases the potential for a transdermal drug delivery system.

TBRC’s injectable drug delivery devices market report covers:

Major Market Players: Becton, Dickinson and Company, Baxter International, Gerresheimer AG, B. Braun Melsungen AG, Catalent, Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Injectable Drug Delivery Devices Market Report 2022 is one of a series of new reports from The Business Research Company that provides injectable drug delivery devices market overviews, analyzes and forecasts market size, share, injectable drug delivery devices market players, injectable drug delivery devices market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s injectable drug delivery devices market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2022

Autoinjectors Global Market Report 2022

Wearable Injectors Global Market Report 2022

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read More About Us At https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn:  https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter:  https://twitter.com/tbrc_info

Check out our Global Market Model:  https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: